Abiopharma

Tuniu to Report Second Quarter 2026 Financial Results on August 25, 2026

Binding agreement for the sale of 20% of Ashtrom Rental Housing to entities from the Migdal group, continuation

The company’s liability position as of 30.6.26, by maturity dates

Investors presentation - Second quarter 2026

Quarter 2/semi-annual report for 2026

Dividend of $0.03844 per share, record date: 20.8.26, payment 3.9.26

Dormant shares - creation of dormant shares

Preliminary notice of intention to convene a general meeting for the approval of the appointment of directors

MindMaze Therapeutics Appoints Prof. John W. Krakauer as Strategic Advisor

Assured Guaranty Guarantees €200 Million of Debt as part of the Refinancing of France’s A28 Toll Road